CIPLAPharmaceuticals
Cipla Ltd — PE Ratio & Valuation Analysis
₹1242.30
+0.19%
Current P/E22.62xPrice to earnings
Industry P/E31.77xSector average
4Y Avg P/E30.9x26.8% below avg
✅
28.8% Discount to Industry
CIPLA P/E 22.62x vs sector avg 31.77x
📊
Historical PE Ratio
| Year | EPS (₹) | Year-end Price | PE Ratio |
|---|---|---|---|
| 2025 | ₹65.24 | ₹1511 | 23.2x |
| 2024 | ₹51.01 | ₹1529 | 30x |
| 2023 | ₹34.69 | ₹1246 | 35.9x |
| 2022 | ₹31.17 | ₹1076 | 34.5x |
PE = Year-end closing price ÷ Diluted EPS. Source: NSE/BSE filings.
💡
Understanding Cipla Ltd Valuation
Cipla Ltd (CIPLA) currently trades at 22.62x earnings. The Pharmaceuticals sector average PE is 31.77x. CIPLA is trading at a discount to peers — may indicate relative value. Historically, CIPLA has traded at an average PE of 30.9x — it is currently below that level. Always evaluate PE alongside earnings growth (PEG ratio), return on equity, debt levels and business quality. A lower PE isn't always better. Educational data only — not investment advice.
ROE
17.77%
Dividend Yield
0.85%
More on Cipla Ltd
Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.